| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f65000462732b10476ce5c6722079716
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b1dae628278f95857080c16f9489999 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-538 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-538
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D265-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
2011-06-07^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35f251e520fd5ef1d5644ace62a43146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_296f00402e4a0fd27d57fb536ec547d6 |
| publicationDate |
2012-02-09^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012034275-A1 |
| titleOfInvention |
Powder formulations for inhalation, comprising enantiomerically pure beta agonists |
| abstract |
The present invention relates to powder formulations for inhalation containing enantiomerically pure compounds of general formula 1 n n n n n n n n n n wherein the groups R 1 , R 2 , R 3 and R 4 may have the meanings given in the claims and in the specification, optionally in the form of the pharmaceutically acceptable acid addition salts thereof, as well as optionally in combination with a pharmaceutically acceptable excipient, processes for preparing them and their use as pharmaceutical compositions, particularly as pharmaceutical compositions for the treatment of respiratory complaints. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8420809-B2 |
| priorityDate |
2004-05-14^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |